- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Armenian Hamster
- Immunogen
- Mouse spleen dendritic cells
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
- Preparation
- The antibody was purified by affinity chromatography and conjugated with Alexa Fluor? 647 under optimal conditions.
- Concentration
- 0.5 mg/mL
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
3D IHC - Verified
IHC - Reported but collaborator, not verified in house
ICC, SB - Reported in the literature, not verified in house
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?L?volume. For 3D immunohistochemistry on formalin-fixed tissues, a concentration of 5.0 ?g/mL is suggested. It is recommended that the reagent be titrated for optimal performance for other applications.
* Alexa Fluor? 647 has a maximum emission of 668 nm when it is excited at 633nm / 635nm.
Alexa Fluor? and Pacific Blue? are trademarks of Life Technologies Corporation.
View full statement regarding label licenses - Excitation Laser
- Red Laser (633 nm)
- Application Notes
Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor? 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.
- Additional Product Notes
Iterative Bleaching Extended multi-pleXity (IBEX) is a fluorescent imaging technique capable of highly-multiplexed spatial analysis. The method relies on cyclical bleaching of panels of fluorescent antibodies in order to image and analyze many markers over multiple cycles of staining, imaging, and, bleaching. It is a community-developed open-access method developed by the Center for Advanced Tissue Imaging (CAT-I) in the National Institute of Allergy and Infectious Diseases (NIAID, NIH).
- Application References
(PubMed link indicates BioLegend citation) -
- Granucci F, et al. 1997. J. Immunol. 159:1794.
- Stokes RW, et al. 1998. J. Immunol. 160:5514.
- Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
- Ma XT, et al. 2006. Cancer Research 66:1169.
- Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
- Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
- Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
- Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
- You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
- Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
- Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
- Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
- Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
- Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
- Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
- Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
- Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
- Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
- Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
- Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
- White CE, et al. 2015. J Immunol. 194:697. PubMed
- Lu X, et al. 2015. J Immunol. 194:2011. PubMed
- Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
- Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
- Product Citations
-
- Vella JL, et al. 2021. Life Sci Alliance. 4:. PubMed
- Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed
- Reboldi A, et al. 2016. Sci Transl Med. 352: aaf4822. PubMed
- Lei G, et al. 2016. Antimicrob Agents Chemother. 60: 1289 - 1297. PubMed
- Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
- Rodda LB et al. 2018. Immunity. 48(5):1014-1028 . PubMed
- Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed
- Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
- Bradford BM, et al. 2018. Parasite Immunol. 40:e12566. PubMed
- Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
- Roufaiel M, et al. 2016. Nat Immunol. 10.1038/ni.3564. PubMed
- Bates J, et al. 2009. J Immunol. 182:7539. PubMed
- Hays C, et al. 2020. eLife. 8:e48772.. PubMed
- Shen H, et al. 2022. Nat Commun. 13:6030. PubMed
- Haugh KA, et al. 2021. eLife. 0.416666666666667. PubMed
- Hagan AS, et al. 2020. Development. 147:00:00. PubMed
- Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
- Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
- An S, et al. 2019. Small. 15:e1805182. PubMed
- Hildebrand KM, et al. 2021. PLoS One. 16:e0253864. PubMed
- Li Y, et al. 2021. Sci Transl Med. 13:. PubMed
- Kishore M et al. 2017. Immunity. 47(5):875-889 . PubMed
- Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
- Kim SH, et al. 2021. Cell Reports. 35(2):108995. PubMed
- Koikawa K, et al. 2021. Cell. 184(18):4753-4771.e27. PubMed
- Collins N, et al. 2016. Nat Commun. 7:11514. PubMed
- Stevenson ER, et al. 2022. J Pharmacol Exp Ther. 382:356. PubMed
- Mambres D, et al. 2016. J Immunol. 196: 3780 - 3793. PubMed
- Vacca F, et al. 2020. eLife. 9:e54017.. PubMed
- Barbet G, et al. 2018. Immunity. 48:584. PubMed
- Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
- Lindhorst A, et al. 2021. Cell Death Dis. 12:579. PubMed
- Chen S, et al. 2015. Blood. 126: 103 - 112. PubMed
- Tran NL, et al. 2022. Elife. 11:. PubMed
- Baker GJ, et al. 2020. Cell Syst. 0.647222222. PubMed
- Silva HM, et al. 2019. J Exp Med. 216:786. PubMed
- Markey KA et al. 2019. Current protocols in immunology. 125(1):e72 . PubMed
- Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
- Fox B, et al. 2016. PLoS One. 12: 1006189. PubMed
- Song W, et al. 2022. Immunity. 55:290. PubMed
- RRID
- AB_492850 (BioLegend Cat. No. 117314) AB_389328 (BioLegend Cat. No. 117312)